Home 首页 About Us 关于我们 Services 服务项目 Cases & FAQ案例与常见问题 Contact 联系我们
English 中文简体
Boao Lecheng · Certified Cell Therapy Centre 博鳌乐城 · 合规细胞治疗中心

Pioneering
Healthcare
Innovation
引领医疗创新
守护生命未来

Advanced regenerative medicine and cell therapy services at China's premier medical tourism free-trade zone — where cutting-edge science meets personalised care. 依托博鳌乐城国际医疗旅游先行区政策优势,提供安全合规、科学个性化的细胞再生医学健康管理服务。

GMP
Nationally certified cell preparation laboratories国家认证 GMP 细胞制备实验室
6
Advanced regenerative medicine therapy programmes再生医学先进治疗项目
3
Top hospital partners in Lecheng Pilot Zone乐城先行区顶尖合作医疗机构
FDA
IND approved mRNA tumour neoantigen vaccine (2025)mRNA 肿瘤疫苗获 FDA 临床申请批准(2025 年)
About Huachu Care关于华初

Science-Backed. Compliant. Personalised. 科学为本 · 合规先行 · 个性关怀

Huachu Care (华初医疗科技) is a medical technology services company based in the Boao Lecheng International Medical Tourism Pilot Zone, Hainan, China. We integrate premium cell products prepared by the Hainan Provincial Stem Cell Engineering Center and partner with top medical institutions to deliver safe, compliant, and personalised cell therapy services — covering preventive youthful vitality health management and advanced disease treatment. 华初医疗科技(HUACHU CARE)坐落于海南省博鳌乐城国际医疗旅游先行区。我们整合海南省干细胞工程中心优质细胞产品,联合乐城顶尖医疗机构,为客户提供安全合规、科学个性化的细胞治疗服务,涵盖年轻态健康管理与再生医学先进治疗两大方向。

Regulatory Compliance合规保障

All programmes operate under the special national "先行先试" policies of the Boao Lecheng Pilot Zone — providing a fully regulated clinical pathway for advanced cell therapies unavailable elsewhere in mainland China.所有项目依托博鳌乐城先行区国家特批政策运营,为内地其他地区无法开展的先进细胞疗法提供合法合规的临床路径。

GMP Quality StandardsGMP 品质标准

Every cell preparation undergoes full QC — sterility, endotoxins, mycoplasma, and cell viability ≥90% — in nationally registered GMP laboratories, with NIFDC independent verification.所有细胞制剂在国家备案 GMP 实验室制备,经无菌、内毒素、支原体及细胞活力(≥90%)全套质检,并通过中检院独立复核。

Expert Medical Teams顶尖医疗团队

Partnered with West China Lecheng Hospital, Ruijin Hainan Hospital, and Ciming Boao International Hospital — each with nationally recognised specialists in their respective fields.与四川大学华西乐城医院、上海瑞金医院海南医院、慈铭博鳌国际医院合作,各配备国家级认可的专科专家团队。

Why Boao Lecheng?为什么选择博鳌乐城?

The Boao Lecheng International Medical Tourism Pilot Zone operates under special national "先行先试" policies permitting clinical use of advanced cell therapies — including stem cell treatments, immune cell therapies, and novel biologics — currently unavailable elsewhere in mainland China. The Hainan Provincial Stem Cell Engineering Center, which supplies and quality-controls all cell preparations used by Huachu Care, has formulated the Pilot Zone's industry quality and inspection standards and participated directly in the legislative framework governing cell therapy in the zone.博鳌乐城国际医疗旅游先行区依托"先行先试"国家特批政策,允许在严格监管下开展干细胞治疗、免疫细胞疗法及新型生物制品等内地其他地区尚未开放的先进疗法。为华初提供全部细胞制剂的海南省干细胞工程中心,不仅主导制定了乐城先行区行业质检标准规范,更深度参与了细胞治疗领域的立法工作,为所有治疗方案提供坚实的法律保障。

National Policy Zone国家特批先行先试区 Industry Standards Setter干细胞行业标准制定机构 Legislative Participation深度参与立法 NIFDC Verified中检院质量复核
Clinical Delivery Partners临床合作医疗机构
01
West China Lecheng Hospital, Sichuan University四川大学华西乐城医院
Public medical institution in Lecheng. Leverages West China Hospital's world-class resources. Delivers mRNA-DC vaccine, heart failure MSC therapy, CeEBV vaccine, and NK cell tumour therapy.博鳌乐城先行区公立医疗机构,依托华西医院顶尖资源,承接 mRNA-DC 疫苗、心衰干细胞治疗、CeEBV 疫苗及 NK 细胞肿瘤治疗。
02
Shanghai Ruijin Hospital Hainan Hospital上海瑞金医院海南医院
Branch of Ruijin Hospital (Shanghai Jiao Tong University), co-building a national regional medical centre with Hainan Provincial People's Hospital. Delivers MSC therapy for knee osteoarthritis.上海交通大学医学院附属瑞金医院海南分院,与海南省人民医院共建国家区域医疗中心,承接膝骨关节炎干细胞治疗。
03
Ciming Boao International Hospital慈铭博鳌国际医院
The first professional medical institution in China to receive national approval for clinical stem cell treatment of diabetes. Delivers MSC therapy for Type 2 Diabetes.国内首家获国家批准开展干细胞临床治疗糖尿病的专业医疗机构,承接 2 型糖尿病干细胞治疗项目。
04
Hainan Provincial Stem Cell Engineering Center海南省干细胞工程中心
Established April 2019. The premier cell technology platform for the Lecheng Pilot Zone — providing GMP cell preparations, setting quality standards, and shaping the legislative backbone for cell therapy.2019 年 4 月成立,博鳌乐城先行区核心细胞技术平台,负责提供 GMP 细胞制剂、制定行业质检标准并参与立法工作。
Safety & Quality Assurance安全与质量保障
GMP Certified LabsGMP 认证实验室All preparations from nationally registered GMP laboratories所有制剂均在国家备案 GMP 实验室制备
Full QC Panel全套质检Sterility, endotoxins, mycoplasma, viability ≥90%, purity & residue无菌、内毒素、支原体、活力 ≥90%、纯度、残留物全套检测
NIFDC Independent Review中检院独立复核Stem cell preparations independently verified by China's National Institutes for Food and Drug Control干细胞制剂已通过国家药品检定研究院独立质量复核
Informed Consent First知情同意优先Detailed informed consent signed before all infusions. Medical-grade pre-assessment screens for contraindications.所有回输前签署详细知情同意书,医疗级前置评估筛查禁忌症。
Services & Programmes服务与项目

Cell Therapy Programmes 细胞疗法 全线服务

From preventive anti-ageing health management to advanced treatment of complex conditions — all services are delivered at licensed partner hospitals in the Boao Lecheng Pilot Zone under full regulatory compliance. Click any programme for full clinical details. 从预防性抗衰老健康管理,到复杂疾病的先进治疗方案——所有服务均在博鳌乐城先行区获批医疗机构内合规执行。点击任意项目查看完整临床详情。

Immune Cell (NK) Infusion免疫细胞(NK 细胞)回输
Autologous NK自体 NK 细胞
Autologous NK Cell Infusion自体 NK 细胞回输

Isolated & expanded from your own peripheral blood (~50 ml). Eliminates senescent "zombie" cells, enhances anti-infection capacity, and prevents early tumours. Culture ~2 weeks.从您自体外周血(约 50 ml)分离扩增,清除体内"僵尸细胞"、增强抗感染能力、预防早期肿瘤,培养约 2 周。

5 billion units/session50 亿单位 / 次Every 6–12 months每 6-12 个月 1 次
RMB 128,000
per session · blood draw required · ~2 week culture每次 · 需提前抽血 · 培养约 2 周
View full details查看详情
Cord Blood NK脐带血 NK 细胞
Umbilical Cord Blood NK Cells脐带血源 NK 细胞回输

Standardised from healthy newborn umbilical cord blood. No blood draw required — available upon appointment. Matching required; suitable for low rejection-risk individuals.来自健康新生儿脐带血的标准化制备,无需抽血,随约随用(需配型,适用于无严重排异风险者)。

5 billion units/session50 亿单位 / 次Every 6–12 months每 6-12 个月 1 次
RMB 98,000
per session · no blood draw · ready on appointment每次 · 无需抽血 · 随约随用
View full details查看详情
Stem Cell (MSC) Infusion间充质干细胞(MSC)回输
Umbilical Cord MSC脐带间充质干细胞
Umbilical Cord Mesenchymal Stem Cells脐带间充质干细胞回输

Allogeneic, from newborn umbilical cord. No matching required, low immunogenicity. Promotes tissue regeneration, reduces chronic inflammation, and improves metabolic function.来源于新生儿脐带(异体),无需配型、免疫原性低。促进组织再生(软骨、肌腱、皮肤),降低慢性炎症、改善代谢。

50 million units/session5000 万单位 / 次Once per year每年 1 次
RMB 98,000
per session · no matching required每次 · 无需配型
View full details查看详情
Adipose-Derived MSC脂肪间充质干细胞
Adipose-Derived Mesenchymal Stem Cells脂肪间充质干细胞回输

Cultured from your own liposuction aspirate. Fully autologous — zero rejection risk. Requires small-volume liposuction in advance; culture period approximately 3 weeks.取材于您自体脂肪抽吸培养,完全自体来源,零排异风险。需提前进行小量抽脂手术,培养周期约 3 周。

50 million units/session5000 万单位 / 次Once per year每年 1 次
RMB 128,000
per session · liposuction required · ~3 week culture每次 · 需提前抽脂 · 培养约 3 周
View full details查看详情
Combination Plans年轻态联合计划
Entry基础
Basic Rejuvenation基础焕活
Umbilical Cord Blood NK (5B) × 1 session. Immunity boost & fatigue relief.脐带血源 NK 细胞(50 亿)× 1 次。提升免疫、抗疲劳。
¥98,000
Repair修复
Deep Repair深度修复
Umbilical Cord MSC (50M) × 1 session. Tissue repair & anti-inflammatory.脐带 MSC(5000 万)× 1 次。组织修复、抗炎。
¥98,000
Most Popular推荐
Annual Premium年度尊享
Cord NK ×1 + Cord MSC ×1. Can be used in separate sessions. Comprehensive youthful vitality management.脐带 NK × 1 + 脐带 MSC × 1(可分次使用)。全面年轻态管理,适合多数高净值人群。
¥186,000
Family家庭
Platinum Family Package铂金家族套餐
Self Annual Premium + Spouse Annual Premium + Parents Basic Rejuvenation × 1 each.本人年度尊享 + 配偶年度尊享 + 父母基础焕活各 1 次。
¥388,000
Service Process服务流程
01
Pre-Assessment行前评估
Health questionnaire, expert review, contraindication screening.健康信息采集、专家预评估、禁忌症筛查。
02
Cell Preparation细胞制备
GMP lab. Full quality inspection report; viability >90%.GMP 实验室制备,附质检报告(活力 >90%)。
03
Arrival & Check-up到达与检查
Baseline exams. Five-star wellness hotel available.基础检查,可安排五星级康养酒店住宿。
04
Infusion输注治疗
IV infusion (~60 min), full medical staff. 1-hour observation.静脉输注(约 60 分钟),全程医护陪护,留院观察 1 小时。
05
Follow-Up后续随访
Health steward follow-up at 1 week, 1, 3 & 6 months.回输后 1 周、1、3、6 个月跟踪随访,建立个人健康档案。

For patients with specific diagnosed conditions. Six advanced regenerative medicine programmes delivered at top hospitals under full national regulatory approval. Click any row for complete clinical details.针对特定确诊疾病患者,华初提供六大再生医学先进治疗项目,均在博鳌乐城先行区获批医疗机构内依规合法执行。点击任意行查看完整临床详情。

01
mRNA-DC Tumour Neoantigen VaccinemRNA-DC 肿瘤新抗原疫苗治疗方案
Personalised immunotherapy for solid tumours. mRNA encoding tumour-specific antigens transfected into patient's own dendritic cells. FDA IND approved 2025. First course: 4 injections.个体化实体肿瘤免疫疗法,肿瘤特异性抗原 mRNA 转染至患者自身树突细胞,2025 年获 FDA 临床申请批准,首疗程共 4 针。
¥600,000 / course / 疗程
West China Lecheng Hospital华西乐城医院
02
MSC Therapy for Heart Failure (HFrEF)间充质干细胞治疗射血分数减低性心衰
Umbilical cord MSC IV infusion for LVEF 25–40%, NYHA class II–IV. Promotes angiogenesis, reduces fibrosis. 3 weekly sessions.脐带 MSC 静脉输注,适用于左室射血分数 25-40%、NYHA II-IV 级心衰患者,促进血管生成、减少纤维化,每周 1 次共 3 次。
¥60,000 / session / 次
West China Lecheng Hospital华西乐城医院
03
MSC Therapy for Knee Osteoarthritis间充质干细胞治疗膝骨关节炎
Intra-articular injection, 25 million MSCs per vial. Reduces pain, improves stiffness, promotes cartilage regeneration. Improvements within 4 weeks, lasting 24+ weeks.每支 2500 万细胞关节腔内注射,减轻疼痛、改善僵硬、促进软骨再生,4 周内可见改善,效果持续 24 周或更长。
¥36,350 / vial / 支
Ruijin Hainan Hospital瑞金海南医院
04
MSC Therapy for Type 2 Diabetes间充质干细胞治疗 2 型糖尿病
For poorly-controlled T2DM (HbA1c 7–10%), UC-MSC IV infusion. May reduce HbA1c and improve islet β-cell function. 3 sessions over 15 days. Weight-based dosing.针对控制不佳的 2 型糖尿病(HbA1c 7-10%),脐带 MSC 静脉输注,可能改善 HbA1c 及胰岛 β 细胞功能,15 天 3 次疗程,按体重计算剂量。
¥174,000–313,200
Ciming Boao Hospital慈铭博鳌国际医院
05
CeEBV Therapeutic Cellular VaccineCeEBV 治疗型细胞疫苗
World's first EBV-targeted cellular vaccine. Developed by West China Hospital. FDA Orphan Drug Designation April 2025. Targets EBV-positive tumours and CAEBV. 5-session course.全球首个靶向 EBV 的细胞疫苗,由四川大学华西医院研发,2025 年 4 月获 FDA 孤儿药资格认定。针对 EBV 阳性肿瘤及慢性活动性 EBV 感染,标准 5 次疗程。
¥80,000 / course / 疗程
West China Lecheng Hospital华西乐城医院
06
Autologous NK Cell Adjuvant Therapy for Tumours自体 NK 细胞辅助治疗实体肿瘤
Peripheral blood NK cells expanded ex vivo and reinfused. Covers 8 major solid tumour types. Combinable with PD-1 inhibitors. Standard 6-session course.外周血 NK 细胞体外扩增后回输,覆盖 8 种高发实体肿瘤,可与 PD-1 抑制剂联用,标准疗程 6 次。
¥298,800 / course / 疗程
West China Lecheng Hospital华西乐城医院
⚠ Content is for reference only and does not constitute clinical diagnosis or treatment advice. All therapy programmes are subject to individual medical assessment and physician approval prior to treatment.⚠ 以上内容仅供参考,不构成临床诊疗意见。所有治疗项目均须经个体化医学评估及医师审批后方可实施。
Anonymous Case Studies匿名案例分享

Real Results, Real People 真实案例 真实改变

The following anonymised case studies are drawn from Huachu Care's clinical records. Individual outcomes vary. These cases are illustrative only and do not constitute medical guarantees. 以下匿名案例来自华初医疗临床记录,个体效果存在差异,仅供参考,不构成疗效保证。

NK Cell TherapyNK 细胞治疗
Female, 56 · Corporate Executive56 岁女性 · 企业高管

Chief complaint: 3 years of persistent fatigue, working >60 hours per week, catching colds more than 5 times per year. After umbilical cord blood NK cell infusion (5 billion), she reported on day 15: "Energy significantly improved, no more afternoon sluggishness." Within six months after treatment, she had only one cold.主诉:三年持续性疲劳,每周工作 >60 小时,每年感冒 >5 次。接受脐带血 NK 细胞回输(50 亿)后,第 15 天反馈:"精力明显好转,下午不再昏沉",治疗后半年内仅感冒 1 次。

✓ Voluntarily underwent a second infusion one year later.✓ 一年后自愿进行第二次回输。
MSC – Knee OsteoarthritisMSC 膝骨关节炎
Male, 62 · Knee pain & restricted mobility62 岁男性 · 膝关节疼痛伴活动受限

X-ray showed mild osteoarthritis. Three months after a single IV infusion of umbilical cord MSC (50 million), he reported: "The clicking in my knees when climbing stairs has lessened. I used to feel pain after walking 5 km, but now I can walk 8 km." Follow-up MRI showed a slight increase in cartilage thickness.X 线示轻度骨关节炎。接受脐带 MSC(5000 万)单次静脉输注后 3 个月,自述"爬楼梯膝盖响减轻,原本走 5 公里就疼,现在能走 8 公里"。随访 MRI 显示软骨厚度略有增加。

✓ MRI confirmed slight increase in articular cartilage thickness.✓ MRI 复查证实软骨厚度略有增加。
MSC – PrediabetesMSC 糖尿病前期
Male, 48 · Prediabetes (HbA1c 6.4%)48 岁男性 · 糖尿病前期(HbA1c 6.4%)

Health check-up revealed HbA1c 6.4% — prediabetes. After one session of umbilical cord MSC combined with dietary and exercise guidance, HbA1c dropped to 5.9% after 6 months. He stopped taking metformin. He reported: "I used to feel very sleepy in the afternoon, but now I am much more energetic."体检发现糖化血红蛋白 6.4%,糖尿病前期。接受脐带 MSC 一次,联合饮食运动指导,6 个月后 HbA1c 降至 5.9%,停用二甲双胍。自述"以前下午总犯困,现在精神好多了"。

✓ HbA1c 6.4% → 5.9% at 6 months. Metformin discontinued.✓ HbA1c 6.4% → 5.9%(6 个月后)。停用二甲双胍。
Frequently Asked Questions常见问题解答

Questions & Answers 与答

Effects vary between individuals. Generally, after immune cell infusion, benefits such as increased energy and reduced cold frequency can last 6–12 months. Stem cell repair effects (e.g., improvement in joint pain) tend to last 12–24 months. We recommend annual immune cell maintenance and stem cell maintenance once every 1–2 years.因人而异。一般免疫细胞回输后,精力提升、感冒频率降低的效果可持续 6-12 个月;干细胞修复效果(如关节疼痛改善)可持续 12-24 个月。建议每年进行一次免疫细胞维护,每 1-2 年进行一次干细胞维护。
The effect depends on the individual's baseline condition. Those in excellent health may not easily perceive changes; those with significant suboptimal health or degenerative changes typically experience more prominent improvements. We recommend quantifying effects using objective indicators — such as immune function tests and inflammatory factor levels — before and after treatment.效果取决于个体基础状态。健康状态极佳者不易察觉变化;有明显亚健康或退行性改变者改善感受更为突出。建议治疗前后通过客观指标(如免疫功能检测、炎症因子水平)量化效果。
Same-day infusion is generally not recommended. The mechanisms of action differ, and simultaneously infusing a large number of allogeneic cells may increase the burden on the immune system. An interval of at least 1–2 weeks is recommended, or sessions may be performed separately as advised by a physician.一般不推荐同一天输注,因为两者作用机制不同,同时大量异体细胞输入可能增加免疫系统负担。建议间隔至少 1-2 周,或遵医嘱分次进行。
There is no strict prohibition, but individualised assessment is required. The generally accepted age range for youthful vitality management is 35–75 years. For those over 75, services may still be considered if general health is good and there are no severe chronic diseases — but a more cautious pre-treatment evaluation is required. Healthy individuals under 25 are generally not recommended.不严格禁止,但需个体化评估。年轻态管理通常接受年龄为 35-75 岁。超过 75 岁者,若身体基础良好、无严重慢病,也可考虑,但需更审慎的术前评估。一般不推荐给 25 岁以下健康人群。
Absolutely yes. Cell infusion does not replace existing treatment for underlying diseases. Under physician guidance, you should continue taking your chronic disease medications and must not stop them on your own. Some patients may require dose reduction after several months due to improved metabolism — but this must be evaluated by a specialist.绝对可以。细胞回输不替代现有基础疾病治疗。在医生指导下,您需要继续服用慢病药物,不可擅自停药。部分患者可能在数月后因代谢改善而需减量,但这必须经专科医生评估。
Extensive clinical studies and long-term follow-ups to date have not found mesenchymal stem cells to be tumorigenic. Umbilical cord mesenchymal stem cells do not have unlimited proliferative capacity, and immune cells are themselves "guardians" that eliminate tumours. All cell products from the Hainan Provincial Stem Cell Engineering Center undergo tumorigenicity testing, ensuring safety.目前大量临床研究及长期随访均未发现间充质干细胞具有致瘤性。脐带间充质干细胞不具备无限增殖能力,免疫细胞本身是清除肿瘤的"卫士"。海南省干细胞工程中心的所有细胞产品均经过成瘤性检测,安全性有保障。
Most adverse reactions are mild and transient: low-grade fever (below 38.5°C) occurs in approximately 10–15% of cases and resolves within 24 hours; mild fatigue or drowsiness occurs in approximately 5–10% and resolves within 1–3 days. Slight redness at the injection site is rare and resolves within a few hours. Severe allergic reactions are extremely rare (<0.1%) and emergency medications and a response team are available on-site.大多数不良反应轻微且短暂:一过性发热(<38.5°C)约占 10-15%,24 小时内缓解;轻度乏力、困倦约占 5-10%,1-3 天内可自行缓解;注射部位微红罕见,数小时内消退。严重过敏反应极罕见(<0.1%),现场备有急救药物和医疗团队。
The process is: (1) Submit preliminary health information for initial screening; (2) Free expert online pre-assessment to confirm suitability; (3) Sign informed consent form and complete payment; (4) Your health steward arranges your itinerary and confirms accommodation (five-star wellness hotel available); (5) Arrive at Boao Lecheng and complete baseline examinations the day before treatment; (6) Treatment day: IV infusion (~60 minutes) with full medical staff accompaniment, followed by 1-hour observation.流程如下:(1)提交健康初筛信息;(2)专家免费线上预评估,确认是否适合;(3)签署知情同意书并支付费用;(4)健康管家安排行程并确认住宿(可选五星级康养酒店);(5)到达博鳌乐城,治疗前日完成基础检查;(6)治疗当日:静脉输注(约 60 分钟),全程医护陪护,留院观察 1 小时。

Have more questions? Our health stewards are ready to help. 还有更多问题?我们的健康管家随时为您解答。

Get In Touch联系我们

Start Your Journey 开启您的 健康之旅

Whether you are exploring our services for yourself or as a referring partner, our health steward team is ready to guide you through every step — from initial assessment to treatment planning and scheduling. 无论您是为自己咨询,还是作为合作推介方,我们的健康管家团队随时为您提供从初步评估到治疗规划的全程专属指导。

Address地址

Huachu Medical Technology Service Centre, Boao Lecheng International Medical Tourism Pilot Zone, Qionghai City, Hainan Province, China中国海南省琼海市博鳌乐城国际医疗旅游先行区 华初医疗科技服务中心

WeChat / WhatsApp

Please email us to receive our direct contact details.请发送邮件至上述邮箱获取微信 / WhatsApp 联系方式。

We respond within 1–2 business days. Your information is kept strictly confidential.我们将在 1-2 个工作日内回复。您的信息将被严格保密。

✓ Thank you — we will be in touch within 1–2 business days.✓ 感谢留言,我们将在 1-2 个工作日内与您联系。